1. Acknowledgement to Referees

   Acknowledgement to Referees 08 November 2016 Pages: 1121 - 1125

2. Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status

   • Tara Swart
   • Michael J. Hurley

   Leading Article 08 November 2016 Pages: 1127 - 1135

   

3. B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence

   • Silke Kinzel
   • Martin S. Weber

   Review Article 14 November 2016 Pages: 1137 - 1148

   

4. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications

   • Melinda Liu
   • Yuan Yu M. Huang
   • Joseph S. Kass

   Review Article 10 November 2016 Pages: 1149 - 1168

5. Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies

   • Tristram A. Lett
   • Henrik Walter
   • Eva J. Brandl

   Review Article 17 October 2016 Pages: 1169 - 1189

6. Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review

   • Rainer Freynhagen
   • Miroslav Backonja
   • Regina Behar

   Review Article Open access 16 November 2016 Pages: 1191 - 1200

7. Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China

   • Yingying Su
   • Gang Liu
   • Weibi Chen

   Original Research Article 23 November 2016 Pages: 1201 - 1207

   

8. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years

   • Mark Zimmerman
   • Carolina Guzman Holst
   • Douglas Gazarian

   Original Research Article 19 August 2016 Pages: 1209 - 1218